OR WAIT 15 SECS
November 23, 2020
The new model will test a new way to lower increasing drug prices for patients paying for drugs under Medicare Part B.
October 08, 2020
Bill SB 852 would address the affordability and accessibility of generic drugs, including insulin and epinephrine, in California.
September 09, 2020
The generic pipeline continues to provide significant value to payers and patients as key products in top therapeutic classes lose patent protection.
September 04, 2020
Pharmacy organizations stress that government initiatives must include an overall plan for drug pricing, payment model, and supply chain transparency.
August 20, 2020
Why do we pharmacists buy generics from foreign manufacturers? The answer is pure and simple: the cost.
Mylan has launched the first FDA-approved generic version of Biogen’s dimethyl fumarate (Tecfidera) for relapsing forms of multiple sclerosis.
August 10, 2020
Pharmacists are in a unique position to recommend cost-saving generics and counsel patients on generic substitution.
August 07, 2020
The advent of generic and biosimilar medicines for novel treatments has helped bridge the gap in the delivery of cancer care between the United States and India, according to the study.
July 14, 2020
Sandoz is collaborating with Civica Rx to provide critical injectable generic medicines to hospitals to help reduce supply shortages.
July 13, 2020
Medicare beneficiary out-of-pocket costs for generic drugs used to treat chronic conditions declined from 2009 to 2017.
